Drug major
Cipla reported a 36.32 per cent increase in net profit to Rs 291.74 crore for the fourth quarter ended March 31, 2012 due to robust sales in international and domestic markets and reduction in material costs.
The company had posted a net profit of Rs 214 crore for the quarter ended March 31,2011, Cipla said in a filing to the BSE.
Total income of the company stood at Rs 1,865.57 crore for the quarter ended March 31, 2012 as against Rs 1,667.74 crore for the corresponding period of previous fiscal.
While domestic revenues for the fourth quarter this year grew by 15.5 per cent to Rs 753.55 crore from Rs 652.23 crore, international business rose by more than 11 per cent to 1,084.96 crore from Rs 974.95 crore for the same period last fiscal, Cipla said.
Material cost at 42 per cent of the total sales decreased by 7.2 per cent for the quarter under consideration from Q4 in the financial year 2010-11, it added.
The company's net profit for the year ended March 31, 2012, rose to Rs 1,123.96 crore from Rs 960.39 crore for the year ago period.
Total income of the company rose to Rs 6,977.50 crore for the year ended March this year from Rs 6,331.09 crore for the corresponding period last year.
Special 
